Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-04-02

Clinical Trial Update: Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial results assess the efficacy and safety of ATs in patients with dry eye syndrome and keratoconjunctivitis sicca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATs

Snippet

Sponsor: Dhp Korea Co., Ltd. | Conditions: Dry Eye Syndromes, Keratoconjunctivitis Sicca | Phase 2 | Status: COMPLETED